 |
 |
 |
|
Population Pharmacokinetics of Cobicistat-Boosted Elvitegravir in Adult Healthy Subjects and HIV-infected Patients
|
|
|
Reported by Jules Levin
13th HIV Clinical Pharmacology Workshop
Apr 16-18 2012 Barcelona Spain
Custodio1, T Gordi2, S Chang1, B Kearney1, and S Ramanathan1
1Gilead Sciences, Inc., Foster City, CA; 2ROSA & CO., San Carlos, CA








|
|
|
 |
 |
|
|